Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphoma, AIDS-Related 1Lymphoma 1Hodgkin Disease 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 6Cyclophosphamide 6Vincristine 5Dexamethasone 5Zidovudine 4Methotrexate 4Leucovorin 4Cytarabine 4Bleomycin 4Filgrastim 3sargramostim 2Etoposide 2Allopurinol 2tocilizumab 1fludarabine phosphate 1fludarabine 1Vinblastine 1Valganciclovir 1Thiotepa 1Tacrolimus 1Rituximab 1Prednisone 1Mitoxantrone 1Mitoguazone 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Melphalan 1Interviews as Topic 1HIV Testing 1Genes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Mitoguazone × Lymphoid × Clear all
NCT00002348 2020-12-19

A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma

Sanofi

Phase 2 Completed
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, AIDS-Related

Data powered by HemOnc (CC BY 4.0) Colophon âš¡